@cottonroot32
Active 3 weeks, 4 days ago
The enza-LA combination, in interim OS data, demonstrated a positive trend (hazard ratio 0.59; 95% confidence interval 0.38-0.91; p=0.0153), failing to exceed the interim efficacy threshold. Meanwhile, enza monotherapy showed a positive trend (hazard ratio 0.78; 95% confidence interval 0.52-1.17; p=0.02304). The prevalent adverse effects […] View
You must be logged in to post a comment.